Clinical Trial Update: Tomivosertib in Relapsed or Refractory Acute Myeloid Leukemia (AML) [Phase 1]

View source ↗

Summary

This entry reports a Phase 1 trial of Tomivosertib in relapsed or refractory acute myeloid leukemia, sponsored by Northwestern University; the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Tomivosertib (tomivosertib)

Snippet

Sponsor: Northwestern University | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: ACTIVE_NOT_RECRUITING